Latest gabapentin Stories
Scientists at The Scripps Research Institute have found clinical evidence that the drug gabapentin, currently on the market to treat neuropathic pain and epilepsy, helps people to quit smoking marijuana (cannabis).
A clinical trial of gabapentin, an epilepsy drug, may have been a â€œseeding trialâ€ that was used by the pharmaceutical company purely for promotional purposes and to increase prescriptions.
The American Academy of Neurology has issued a new guideline on the most effective treatments for diabetic nerve pain -- the burning or tingling pain in the hands and feet that affects millions of people with diabetes.
SILVER SPRING, Md., April 7, 2011 /PRNewswire-USNewswire/ -- On April 6, the U.S. Food and Drug Administration approved Horizant Extended Release Tablets (gabapentin enacarbil), a once-daily treatment for moderate-to-severe restless legs syndrome (RLS).
STAINES, England, February 28, 2011 /PRNewswire-FirstCall/ -- - Decision to Reimburse Qutenza(TM) (capsaicin 8% w/w dermal patch) by Sweden's Dental and Pharmaceutical Benefits Agency (Tand-och Lakemedelsformansverket) Gives new Option to Patients Living With Difficult-to-Treat Condition Patients in Sweden living with peripheral neuropathic pain are set to gain access to a new treatment option which can provide pain relief for up to three months following a single 30- or 60-minute...
PITTSBURGH, Feb. 28, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S.
Most anti-epileptic drugs are associated with an increased risk of non-traumatic fracture in individuals 50 years of age and older.
KANSAS CITY, Mo., Nov. 17, 2010 /PRNewswire/ -- Teva Neuroscience today announced the addition of an 11th member to Team COPAXONEÂ® (glatiramer acetate injection); continuing a year-long celebration of the Team's 10 years of advocacy within the multiple sclerosis (MS) community.
BURLINGTON, Mass., Oct. 6 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, although NeurogesX/Astellas's Qutenza is only approved for postherpetic neuralgia, surveyed U.S.
- Easily ashamed, having a strong sense of shame; modest; chaste.
- Of or pertaining to the external organs of generation.